Erin Whalen, based in South San Francisco, CA, US, is currently a Executive Director - Cardiometabolic Disorders Research at Amgen, bringing experience from previous roles at Novo Nordisk and Novartis Institutes for Biomedical Research (Nibr). Erin Whalen holds a . With a robust skill set that includes Clinical Development, Science, Clinical Research, Cell Culture, Cell Based Assays and more, Erin Whalen contributes valuable insights to the industry. Erin Whalen has 4 emails and 1 mobile phone number on RocketReach.